{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:13:14Z","timestamp":1791094394632,"version":"4.1.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2003,3,5]]},"DOI":"10.1001\/jama.289.9.1136","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T15:05:58Z","timestamp":1047999958000},"page":"1136","source":"Crossref","is-referenced-by-count":142,"title":["Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease"],"prefix":"10.1001","volume":"289","author":[{"given":"Debra L.","family":"Weiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Hibberd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Betit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Brugnara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ref-jpc30001-3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia: a possible determinant of disease severity.","volume":"302","author":"Hebbel","year":"1980","journal-title":"N Engl J Med"},{"key":"ref-jpc30001-4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0022-2143(97)90176-1","article-title":"The endothelial biology of sickle cell disease.","volume":"129","author":"Hebbel","year":"1997","journal-title":"J Lab Clin Med"},{"key":"ref-jpc30001-5","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1182\/blood.V97.6.1584","article-title":"Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation.","volume":"97","author":"Belhassen","year":"2001","journal-title":"Blood"},{"key":"ref-jpc30001-6","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.","volume":"96","author":"Belcher","year":"2000","journal-title":"Blood"},{"key":"ref-jpc30001-7","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1056\/NEJM199711273372203","article-title":"Circulating activated endothelial cells in sickle cell anemia.","volume":"337","author":"Solovey","year":"1997","journal-title":"N Engl J Med"},{"key":"ref-jpc30001-8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia.","volume":"129","author":"Wun","year":"1997","journal-title":"J Lab Clin Med"},{"key":"ref-jpc30001-9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.","volume":"106","author":"Kaul","year":"2000","journal-title":"J Clin Invest"},{"key":"ref-jpc30001-10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0037-1963(01)90027-7","article-title":"Nitric oxide therapy in sickle cell disease.","volume":"38","author":"Gladwin","year":"2001","journal-title":"Semin Hematol"},{"key":"ref-jpc30001-11","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway.","volume":"329","author":"Moncada","year":"1993","journal-title":"N Engl J Med"},{"key":"ref-jpc30001-12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/(ISSN)1096-8652","article-title":"Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis.","volume":"64","author":"Lopez","year":"2000","journal-title":"Am J Hematol"},{"key":"ref-jpc30001-13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/00043426-200011000-00009","article-title":"Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.","volume":"22","author":"Morris","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref-jpc30001-14","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide biovailability in sickle-cell disease.","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"ref-jpc30001-16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/0140-6736(92)92686-A","article-title":"Inhaled nitric oxide in pulmonary hypertension of the newborn.","volume":"340","author":"Roberts","year":"1992","journal-title":"Lancet"},{"key":"ref-jpc30001-17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension.","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"key":"ref-jpc30001-18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.","volume":"336","author":"The Neonatal Inhaled Nitric Oxide Group","year":"1997","journal-title":"N Engl J Med"},{"key":"ref-jpc30001-19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJM199302113280605","article-title":"Inhaled nitric oxide for the adult respiratory distress syndrome.","volume":"328","author":"Rossaint","year":"1993","journal-title":"N Engl J Med"},{"key":"ref-jpc30001-20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1067\/mtc.2001.115158","article-title":"Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin.","volume":"122","author":"Kalweit","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref-jpc30001-21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/00000542-199710000-00037","article-title":"Inhaled nitric oxide in sickle cell disease with acute chest syndrome.","volume":"87","author":"Atz","year":"1997","journal-title":"Anesthesiology"},{"key":"ref-jpc30001-22","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1097\/00003246-199911000-00039","article-title":"Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent.","volume":"27","author":"Sullivan","year":"1999","journal-title":"Crit Care Med"},{"key":"ref-jpc30001-23","first-page":"111","article-title":"Enrolling patients into clinical trials faster using RealTime Recruiting.","author":"Butte","year":"2000","journal-title":"Proc AMIA Symp"},{"key":"ref-jpc30001-24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1067\/mem.2003.52","article-title":"Computerized recruiting for clinical trials in real time.","volume":"41","author":"Weiner","year":"2003","journal-title":"Ann Emerg Med"},{"key":"ref-jpc30001-25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/00000542-200106000-00028","article-title":"Inhaled nitric oxide improves survival rates during hypoxia in a sickle cell (SAD) mouse model.","volume":"94","author":"Martinez-Ruiz","year":"2001","journal-title":"Anesthesiology"},{"key":"ref-jpc30001-27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0304-3959(93)90163-J","article-title":"Toward validation of pain measurement tools for children: a pilot study.","volume":"52","author":"Tyler","year":"1993","journal-title":"Pain"},{"key":"ref-jpc30001-29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00006565-199906000-00004","article-title":"Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.","volume":"15","author":"Hardwick Jr","year":"1999","journal-title":"Pediatr Emerg Care"},{"key":"ref-jpc30001-30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0196-0644(96)70238-X","article-title":"Clinical significance of reported changes in pain severity.","volume":"27","author":"Todd","year":"1996","journal-title":"Ann Emerg Med"},{"key":"ref-jpc30001-31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1067\/mem.2001.118863","article-title":"Prospective validation of clinically important changes in pain severity measured on a visual analog scale.","volume":"38","author":"Gallagher","year":"2001","journal-title":"Ann Emerg Med"},{"key":"ref-jpc30001-32","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1172\/JCI119631","article-title":"Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.","volume":"100","author":"Head","year":"1997","journal-title":"J Clin Invest"},{"key":"ref-jpc30001-33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1006\/bbrc.2000.3413","article-title":"Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes.","volume":"275","author":"Hrinczenko","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"ref-jpc30001-34","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1172\/JCI7637","article-title":"Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.","volume":"104","author":"Gladwin","year":"1999","journal-title":"J Clin Invest"},{"key":"ref-jpc30001-35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/34402","article-title":"Reactions between nitric oxide and haemoglobin under physiological conditions.","volume":"391","author":"Gow","year":"1998","journal-title":"Nature"},{"key":"ref-jpc30001-36","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.286.17.2099","article-title":"Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial.","volume":"286","author":"Orringer","year":"2001","journal-title":"JAMA"},{"key":"ref-jpc30001-37","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1124\/mol.55.6.1006","article-title":"Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea.","volume":"55","author":"Glover","year":"1999","journal-title":"Mol Pharmacol"},{"key":"ref-jpc30001-38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1365-2141.2002.03274.x","article-title":"Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease.","volume":"116","author":"Gladwin","year":"2002","journal-title":"Br J Haematol"},{"key":"ref-jpc30001-39","first-page":"498","article-title":"Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease.","volume":"111","author":"Morris","year":"2000","journal-title":"Br J Haematol"},{"key":"ref-jpc30001-1","first-page":"395","article-title":"Natural history of disease: the first two decades.","volume-title":"Sickle Cell Disease: Basic Principles and Clinical Practice","author":"Powars","year":"1994"},{"key":"ref-jpc30001-2","first-page":"531","article-title":"The acute painful episode.","volume-title":"Sickle Cell Disease: Basic Principles and Clinical Practice","author":"Shapiro","year":"1994"},{"key":"ref-jpc30001-15","volume-title":"Inhibition of nitric oxide synthase induces acute vaso-occlusive crisis in transgenic sickle mice. Paper presented at: American Society of Hematology","author":"Holtzman","year":"2000"},{"key":"ref-jpc30001-26","volume-title":"Acute Pain Management: Operative or Medical Procedures and Trauma: Clinical Practice Guideline","author":"Acute Pain Management Guideline Panel","year":"1992"},{"key":"ref-jpc30001-28","first-page":"671","article-title":"Nature and treatment of the acute painful episode in sickle cell disease.","volume-title":"Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management","author":"Benjamin","year":"2001"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/196102\/jpc30001_1136_1142_1651264370.94913.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:01:39Z","timestamp":1651276899000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/196102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,5]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,3,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.289.9.1136","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,5]]}}}